Treatment Options for HER2+ Breast Cancer: A Comprehensive Guide

What are the best treatment options for HER2-positive breast cancer? In this video, Dr. Jennifer Griggs explores the newest advancements in treating HER2+ breast cancer, including targeted therapies like Trastuzumab (Herceptin), Pertuzumab (Perjeta), T-DM1 (Kadcyla), and Neratinib (Nerlynx). Learn how these treatments work to specifically target HER2-positive cancer cells and their benefits.

Get your personalized Yerbba Report at https://www.yerbba.com/

Connect With Yerbba!
INSTAGRAM:   / yerbba  
FACEBOOK:   / yerbba.breast.cancer  
BLOG: https://www.yerbba.com/blog

#her2positive #targetedtherapy #breastcancertreatment

References:
NSABP 31 Trial: https://www.nejm.org/doi/full/10.1056...
HERA Trial: https://pubmed.ncbi.nlm.nih.gov/28215...
6 vs. 12 Months of Trastuzumab: https://www.thelancet.com/journals/la...
EMILIA Trial: https://pubmed.ncbi.nlm.nih.gov/28526...
Nerlynx Research: https://pubmed.ncbi.nlm.nih.gov/33183...

Chapters
0:00 Introduction
0:32 An Overview of HER2+
1:56 Research Findings
3:50 Trastuzumab and Pertuzumab
5:42 T-DM1 (Ado-Trastuzumab)
6:25 Neratinib (Nerlynx)
6:53 What to Expect From New Treatments

Disclaimer: Yerbba YouTube videos are for informational purposes only, do not constitute medical advice, and are not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your medical team, mental health professional, or other qualified health provider with any questions you may have regarding your medical condition.